Deactivation of cell death pathways (e.g., ceramide, apoptosis stimulating kinase, ASK1) (4) and avoidance of immune surveillance (5, 6) play major roles in desensitizing cancer cells to treatments irrespective of nature of treatments. The gene discussed is MAP3K5; the disease is cancer.